What we have learned about antenatal corticosteroid regimens

被引:11
|
作者
Wapner, Ronald J. [1 ]
Gyamfi-Bannerman, Cynthia [1 ]
Thom, Elizabeth A. [2 ]
机构
[1] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, New York, NY 10032 USA
[2] George Washington Univ, Ctr Biostat, Washington, DC USA
关键词
Antenatal corticosteroids; Betamethasone; Preterm Birth; Respiratory distress; RESPIRATORY-DISTRESS-SYNDROME; BIRTH-WEIGHT INFANTS; MULTIPLE COURSES; PRETERM BIRTH; NEURODEVELOPMENTAL OUTCOMES; CONTROLLED-TRIAL; TERM OUTCOMES; SINGLE; DEXAMETHASONE; BETAMETHASONE;
D O I
10.1053/j.semperi.2016.03.005
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Administration of antenatal corticosteroids has been standard of care for women between 24 and 34 weeks of gestation who are at risk for preterm delivery for more than 20 years longer in other parts of the world. Although the benefit of steroids in this population has been confirmed, there remain many questions including the frequency of dosing and whether it is possible to expand the gestational age criteria to women likely to deliver before 24 weeks or after 34 weeks. The MFMU Network has played a major role in answering some of these questions. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:291 / 297
页数:7
相关论文
共 50 条